C57BL/6-Tg(Gt(ROSA)26Sor-ALPP*)192Biat/Biat

Status

Available to order

EMMA IDEM:10666
International strain nameC57BL/6-Tg(Gt(ROSA)26Sor-ALPP*)192Biat/Biat
Alternative nameC57BL/6N-Tg(R26-ALPPm)192Biat [Tg(ALPPm)] ; LabNames: TG(ALPP), ALPP recipient strain (ALPP19
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Gt(ROSA)26Sor-ALPP*)192Biat
Gene/Transgene symbolTg(Gt(ROSA)26Sor-ALPP*)192Biat

Information from provider

ProviderReinhold Erben
Provider affiliationDepartment 1 (Biomedical Sciences), University of Veterinary Medicine, Vienna
Genetic informationTo generate ALPP tolerant recipients (line 2), ALPP´s unique heat stability was used: changing glutamic acid 451 to glycine was sufficient to render the protein heat-labile. This heat-labile form of ALPP can easily be distinguished from wild-type ALPP by heat inactivation, similar to endogenous APs. These recipient animals show complete immuno-tolerance versus wild-type ALPP (versus cells/tissues, transplanted from the donor line), as this mutated form of ALPP is virtually identical to native ALPP. Mutations: Human Alkaline Phosphatase (hPLAP) and Gt(ROSA)26Sor promoter (R26) was amplified from transgenic Fischer 344 rats ubiquitously expressing hPLAP (Kisseberth et al, 1999, Developmental Biology 214, 128 - 138). A single point mutation (A to G) was introduced via splice overlap extension resulting in an amino acid substitution at position 429 (glutamic acid to glycine); effect: loss of heat stability of the gene product. Teansgenic animals were created by pronuclear injection of mouse zygotes and random integration of the transgene. Phenotype: ubiquitous expression (low level) of the mutated marker protein hPLAP (heat labile); size of transgene: 5142 bp.
Phenotypic informationHomozygous:
No overt phenotype; histologically: ubiquitously positive staining of the human PLAP protein in transgenic animals, gone after heat inactivation (like mouse AP)

Heterozygous:
No overt phenotype; histologically: ubiquitously positive staining of the human PLAP protein in transgenic animals, gone after heat inactivation (like mouse AP)
Breeding historyCreated in 2007 on C57BL/6, constantly crossed with C57BL/6N (20 generations minimum); breeding system: tg x C57BL/6; next generation: C57BL/6 x tg (male and female heredity alternating)
ReferencesNone available
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivingheterozygous C57BL/6N

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).